Hana Biosciences (HNAB.OB) Announces “Promising” Phase II Data for Adult Acute Lymphoblastic Leukemia Trials
Biopharmaceutical company Hana Biosciences focuses on enhancing cancer care. The company yesterday announced the completion of its phase II rALLY…